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ttp://dx.doi.org/10.1016/j.ajpath.2015.01.009Mouse models are used to study mechanisms that link intrauterine infection and preterm birth (PTB).
To mimic intrauterine infection, lipopolysaccharide (LPS) is commonly injected into the uterus via
minilaparotomy, which is invasive, and can cause PTB in control animals. We hypothesized that less-
invasive ultrasound-guided intrauterine LPS injection or intravaginal LPS administration could
induce PTB by stimulating an inﬂammatory response of the uteroplacental tissues, while minimizing
PTB in control animals. On day 17 of gestation mice received LPS intravaginally (10 to 240 mg; nZ 3
to 8) or into the uterus (20 mg) under ultrasound guidance (n Z 7) or via laparotomy (n Z 7).
Control animals received phosphate-buffered saline (PBS; nZ 5 to 7). Intrauterine administration of
LPS, both under ultrasound guidance and via laparotomy, induced delivery earlier than in PBS control
groups (P< 0.01). Intravaginal LPS administration did not stimulate PTB. Quantitative real-time PCR
and immunohistochemistry of tissues harvested 6 hours after treatment conﬁrmed that ultrasound-
guided LPS administration induced a localized inﬂammatory response. Ultrasound-guided intra-
uterine LPS injection reliably induces PTB in the mouse and mimics the local inﬂammatory and
immune responses observed in the more-invasive laparotomy model of inﬂammation-induced PTB.
Ultrasound-guided intrauterine LPS injection is a useful novel model of PTB for future studies and
concords with the principles of reduction, replacement, and reﬁnement. (Am J Pathol 2015, 185:
1201e1206; http://dx.doi.org/10.1016/j.ajpath.2015.01.009)Supported by Tommy’s Baby Charity (S.F.R., S.M., L.F., J.E.N., and
S.J.S.) and Medical Research Council project grant MR/L002647/1 (S.F.R.).
Disclosures: None declared.Preterm birth (PTB), deﬁned as delivery before 37 weeks of
gestation, remains a major public health problem, estimated
to affect 11.1% of pregnancies worldwide and is the single
biggest cause of neonatal mortality and morbidity.1 Rates of
PTB have remained relatively unchanged in recent decades
because of a lack of effective treatments to prevent preterm
labor.2 The development of novel therapeutic treatments is
hindered by a lack of understanding of the causes of PTB in
many cases.
Intrauterine infection and/or inﬂammation is thought to be
a major cause of PTB and is estimated to be present in up to
40% of preterm deliveries.3 Animal studies have conﬁrmed
a direct causal link between infection and inﬂammation
and PTB, where intrauterine or systemic administration ofstigative Pathology.
.bacterial products such as lipopolysaccharide (LPS) or
proinﬂammatory cytokines, such as tumor necrosis factor-a
(TNF-a) or IL-1b, effectively induce preterm labor.4e8
Given the practical and ethical issues that surround the
collection of tissues from pregnant women and the testing of
novel interventions without prior in vivo proof of concept,
animal models are invaluable in improving our under-
standing of the mechanisms that link intrauterine infection
and inﬂammation and PTB and to investigate the potential
of novel therapeutic options for PTB. The mouse is the most
Figure 1 Models of intrauterine LPS-induced
PTB. In the laparotomy model of PTB the uterine
horns are exposed via minilaparotomy procedure
(A), and PBS or LPS is injected directly into the
uterus between two gestational sacs (B). In the
ultrasound-guided model, an appropriate intra-
uterine space was identiﬁed sonographically (C),
and 25 mL of ultrasound contrast agent was
injected directly into the uterus, between two
gestational sacs, under ultrasound guidance to
verify the feasibility of the technique (D).
LPS, lipopolysaccharide; PBS, phosphate-buffered
saline; PTB, preterm birth.
Rinaldi et alcommonly used animal model in PTB research.9,10 To
recapitulate the clinical scenario in women, where the
infection is usually localized to within the uteroplacental
unit and subclinical, mouse models of localized intrauterine
infection were developed and used successfully for many
years to explore the mechanisms of PTB. To achieve this, a
minilaparotomy procedure is commonly performed to
expose the uterine horns, and bacterial products such as LPS
are then directly injected into the uterus.5,11e13 Although
effective in achieving early parturition, this method is
invasive for the animals, and laparotomy itself can result in
PTB in control animals, even in the absence of LPS. (This is
perhaps not surprising, given that abdominal surgery in
women is associated with an increased risk of PTB.14) The
resulting variability in outcome necessitates a relatively
large sample size in experiments. In addition, we have
previously reported that the laparotomy procedure induced a
neutrophil inﬂux in the connective tissue layer that sur-
rounds the myometrial muscle bundles of mice treated with
phosphate-buffered saline (PBS), which were absent in tis-
sue from untreated control mice, highlighting that the lap-
arotomy procedure itself can induce a rapid localized
inﬂammatory response even without LPS administration.11
An alternative, less-invasive model of inﬂammation-
induced PTB that is reported involves intravaginal LPS
administration.15e17 This model is proposed to mimic a sub-
clinical vaginal infection, which can ascend to the cervix and
induce an inﬂammatory response, resulting in pretermdelivery.
We investigated whether less-invasive methods could
reliably induce preterm labor and result in a similar local
inﬂammatory and immune responses as was previously
reported in laparotomy-based models in response to
LPS,11,13 while minimizing inﬂammation in the control
(PBS) group. We hypothesized that being less invasive,1202intravaginal LPS inoculation and ultrasound-guided in-
trauterine LPS injection would result in fewer PTBs in
the control group, while maintaining the local inﬂam-
matory response of the uteroplacental tissues of LPS-
treated animals and hence effectively inducing PTB in
the LPS-treated group.
Materials and Methods
Animals
All animal studies were conducted under a UK Home Ofﬁce
license to J.E.N. (60/4241) in accordance with the Animals
Scientiﬁc Procedures Act (1986). Timed-pregnant C57Bl/6
mice were purchased from Charles River Laboratories (Mar-
gate, UK) on D9 to D11 of gestation (the day vaginal plug was
found was designated as D1 of gestation). Mice were accli-
matized for a minimum of 6 days before use.
Laparotomy Model of PTB
As previously described,11,13 on D17 of gestation, a min-
ilaparotomy procedure was performed to expose the uter-
ine horns (Figure 1A), and mice received an intrauterine
injection of LPS (20 mg; from Escherichia coli 0111:B4;
Sigma-Aldrich, Poole, UK; nZ 7) or sterile PBS (Gibco,
Life Technologies Ltd., Paisley, UK; n Z 7) each in a
25-mL volume by using a 33-gauge Hamilton syringe
(Figure 1B).
Intravaginal Model of PTB
On D17 of gestation, mice were anesthetized with isoﬂurane,
and mice received an intravaginal administration of LPSajp.amjpathol.org - The American Journal of Pathology
New Mouse Model of Preterm Birth(20 to 240 mg; from E. coli O111:B4; nZ 3 to 4) or sterile
PBS (nZ 5) each in a volume of 40 mL by using a 200-mL
pipette tip. In a separate cohort, on D16 of gestation, mice
received intravaginal administration of LPS (250 mg; from
E. coli O55:B5; Sigma-Aldrich; nZ 8) or sterile PBS (nZ
5) each in a volume of 100 mL by using a 200-mL pipette tip.
Ultrasound-Guided Intrauterine LPS Administration
PTB Model
For all ultrasound experiments, mice were anesthetized with
isoﬂurane (5% for induction, 1.5% for maintenance) in
oxygen and were positioned supine on the ultrasound stage.
Temperature and heart rate were monitored throughout all
procedures. Abdominal hair was clipped, and residual hair
was removed with depilatory cream, and warmed ultrasound
gel was applied to the abdomen. Scans were performed with
the Vevo 770 high-frequency ultrasound scanner (FUJI-
FILM VisualSonics, Inc., Toronto, ON, Canada) with a
RMV 707B probe (center frequency, 30 MHz). The number
of viable pups was determined before any procedure.
Pilot experiments were performed with only ultrasound
contrast agent to conﬁrm it was possible to use ultrasound to
guide an intrauterine injection between two amniotic sacs.
An appropriate space between two gestational sacs was
identiﬁed sonographically (Figure 1C), and 25 mL of ultra-
sound contrast agent (SonoVue; sulfur hexaﬂuoride micro-
bubbles; Bracco UK Limited, High Wycombe, UK) was
injected under direct ultrasound guidance by using a 33-gauge
Hamilton syringe into the intrauterine space (Figure 1D). In a
separate cohort of animals, 25 mL of methylene blue dye was
injected. Animals were sacriﬁced and tissues were examined,
which conﬁrmed methylene blue dye was in the uterine wall
and space between amniotic sacs but not in the amniotic
cavity. These experiments conﬁrmed the feasibility of using
ultrasound guidance to inject directly into the uterus. We then
examined the effects of intrauterine LPS administration by
using the same method, replacing ultrasound contrast agent/
dye with LPS or PBS. As before, on D17 of gestation, 20 mg
of LPS (from E. coli 0111:B4; nZ 7) or PBS (nZ 6), each
in a volume of 25 mL, was injected directly into the intra-
uterine space between two gestational sacs under ultrasound
guidance.
Time-to-Delivery Experiments
After treatment, mice were placed in individual cages and
continuously monitored with individual closed circuit tele-
vision cameras and a digital video recorder. Time to de-
livery was recorded and deﬁned as the number of hours
from the time of LPS injection to delivery of the ﬁrst pup.
Within 12 to 24 hours of delivery, the number of live/dead
pups was recorded, and the proportion of live born pups was
calculated by dividing the number of live pups by the
number of viable pups counted in utero either at laparotomy
or via ultrasound.The American Journal of Pathology - ajp.amjpathol.orgTissue Collection
In a separate cohort of mice, to determine whether ultrasound-
guided intrauterine LPS administration induced a local in-
ﬂammatory response in the uteroplacental tissues, mice were
sacriﬁced by lethal exposure to carbon dioxide 6 hours after
treatment with LPS (n Z 6) or PBS (n Z 6), and uterine,
placental, and fetal membrane samples were collected and
stored in RNAlater (Sigma-Aldrich) at 80C for quantita-
tive real-time-PCR (qPCR) analysis. Uterine and fetal mem-
brane samples were also ﬁxed in 4% neutral buffered formalin
and embedded in parafﬁn blocks for immunohistochemical
analysis.
qPCR
Total RNA was extracted from the uterus, fetal membranes,
and placental tissue collected 6 hours after surgery by using
the RNeasy mini kit (Qiagen, Crawley, UK) as per the man-
ufacturer’s guidelines. Total RNA (300 ng) was reverse
transcribed with the High Capacity cDNA Reverse Tran-
scription kit (Applied Biosystems, Life Technologies Ltd.,
Paisley, UK). Pre-designed gene expression assays from
Applied Biosystems were used to examine the expression of
Cxcl1 (Mm04207460_m1), Cxcl2 (Mm00436450_m1),Ccl2
(Mm00441242_m1), Il1b (Mm00434228_m1), and Tnfa
(Mm99999068_m1). Primer and probe sequences for Actb,
Ptgs2, and Il6 were designed with Primer Express software
version 3.0 (Life Technologies Ltd.) as follows:Actb forward,
50-GCTTCTTTGCAGCTCCTTCGT-30; Actb reverse, 50-GC-
GCAGCGATATCGTCATC-30; Actb probe, 50-CACCCGC-
CACCAGTTCGCCAT-30; Il6 forward, 50-CCACGGCCTTC-
CCTACTTC-30; Il6 reverse, 50-TGCACAACTCTTTTCTCA-
TTCCA-30; Il6 probe, 50-TCACAGAGGATACCACTCC-
CAACAGACCTG-30; Ptgs2 forward, 50-GCTTCGGGAGC-
ACAACAG-30, Ptsg2 reverse, 50-TGGTTTGGAATAGTTG-
CTC-30; and Ptgs2 probe, 50-TGTGCGACATACTCAAG-
CA-30. Target gene expression was normalized for RNA
loading by using Actb, and the expression in each sample
was calculated relative to a calibrator sample (untreated D17
uterus, fetal membranes, or placenta), which was included in
all reactions, using the 2DDCt method of analysis. All qPCR
analyseswere performed on anAppliedBiosystems 7900HT
instrument.
Immunohistochemistry
Tissue sections (5 mm) were dewaxed in xylene and rehy-
drated in ethanol. Endogenous peroxidase activity was
blocked by incubating slides for 30 minutes in 3% hydrogen
peroxidase. To block nonspeciﬁc binding, slides were
incubated for 30 minutes at room temperature in 5% normal
goat serum. Sections were then incubated overnight at 4C
with rat antieLy-6G (dilution 1:500; BioLegend, San
Diego, CA), a neutrophil surface protein. In negative control
sections, the primary antibody was replaced with normal1203
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Figure 2 Effect of intrauterine LPS administration on time to delivery
and the proportion of live born pups. Time to delivery (A) and the pro-
portion of live born pups (B) were determined in mice treated with intra-
uterine PBS or 20 mg of LPS via minilaparotomy procedure. In the
ultrasound-guided model, time to delivery (C) and the proportion of live
born pups (D) were determined in mice administered intrauterine PBS or
20 mg of LPS under ultrasound guidance. Data are expressed as means SEM.
n Z 7 (B, PBS), n Z 6 (D, PBS), n Z 7 (B and D, LPS). **P < 0.01,
***P < 0.001. LPS, lipopolysaccharide; PBS, phosphate-buffered saline.
Rinaldi et algoat serum. All sections were then incubated with the sec-
ondary antibody (ImmPRESS anti-rat IgG reagent; Vector
Laboratories, Peterborough, UK) for 30 minutes at room
temperature, and positive staining was detected with 3,30-
diaminobenzidine substrate for peroxidase for 5 minutes.
Sections were counterstained in hematoxylin, dehydrated in
ethanol, and mounted. Images were obtained with a PROVIS
microscope (Olympus Optical, Hamburg, Germany) and
AxioVisionRel software version 4.8 (Zeiss, Cambridge, UK).
Statistical Analysis
Data are expressed as means  SEM. Time-to-delivery data
were log-transformed before analysis, and the proportion of
live born pups was arc-sin transformed before analysis. Data
were analyzed by unpaired t-tests. All statistical analyses
were performed with GraphPad Prism software version 6.0
(GraphPad, San Diego, CA). P < 0.05 was considered
statistically signiﬁcant.
Results
Intrauterine LPS Administration by Laparotomy or
Ultrasound-Guided Injection Induces PTB and Reduces
the Proportion of Live Born Pups
To compare and optimize an inﬂammatory model of PTB,
three separate models were investigated. Intravaginal LPS
administration was investigated because it was previously
reported to reliably induce PTB.15,16 However, we were
unable to induce PTB across a wide range of doses (20 to
240 mg) by using the same LPS we have used in the intra-
uterine models (LPS from E. coli 0111:B4) (Supplemental
Figure S1A). In addition, we were unable to replicate pre-
viously published studies by using a different LPS serotype
(250 mg LPS from E. coli 055:B5) (Supplemental
Figure S1B).15,16 We therefore abandoned further attempts
at the vaginal LPS model and subsequently focused our
studies on two models of intrauterine inﬂammation-induced
PTB. Intrauterine administration of 20 mg of LPS via a
minilaparotomy procedure induced delivery signiﬁcantly
earlier than mice receiving PBS (LPS mean time to delivery
of 22.75  1.34 hours versus PBS mean time to delivery of
59.74  9.45 hours; P < 0.01) (Figure 2A). Intrauterine
LPS administration via minilaparotomy also resulted in a
signiﬁcant reduction in the proportion of live born pups
compared with the PBS control group (no live pups born to
LPS-treated mice; mean proportion of live born pups in PBS
group, 0.46  1.4; P < 0.01) (Figure 2B). Ultrasound-
guided intrauterine LPS administration also resulted in
PTB (LPS mean time to delivery of 24.75  8.70 hours
versus PBS mean time to delivery of 61.17  3.37 hours;
P < 0.01) (Figure 2C) and a signiﬁcant reduction in the
proportion of live born pups, compared with the PBS con-
trol group (LPS mean proportion of live born pups,
0.11  0.11 versus 0.91  0.05; P < 0.0001) (Figure 2D).1204Ultrasound-Guided Intrauterine LPS Administration
Induces an Inﬂammatory Response in the
Uteroplacental Tissues
To investigate whether ultrasound-guided intrauterine LPS
administration induced a similar local inﬂammatory response
in the uteroplacental tissues as previously described with the
laparotomy model of PTB,5,18,19 uteroplacental tissues were
collected 6 hours after PBS or LPS treatment and analyzed by
qPCR for the expression of several genes classically associ-
ated with the onset of parturition. In the uterus and placenta,
intrauterine LPS treatment resulted in signiﬁcantly elevated
expression of Cxcl1 (P < 0.0001), Cxcl2 (P < 0.0001), Ccl2
(P < 0.0001), Il1b (P < 0.0001), Il6 (P < 0.0001), Ptgs2
(P < 0.0001), and Tnfa (P < 0.0001) (Table 1), compared
with PBS-treated mice. Similarly, in the fetal membranes in-
trauterine LPS administration resulted in signiﬁcantly elevated
expression of Cxcl1 (P < 0.001), Cxcl2 (P < 0.0001), Ccl2
(P < 0.01), Il1b (P < 0.0001), Ptgs2 (P < 0.01), and Tnfa
(P < 0.001), compared with the PBS control mice. Il6
expression in the fetal membranes was 2.39-fold higher in
LPS-treated mice than in PBS-treated mice; however, this did
not reach statistical signiﬁcance (PZ 0.055) (Table 1).
Neutrophil Inﬂux in Response to Ultrasound-Guided
Intrauterine LPS
To determine whether ultrasound-guided intrauterine LPS
administration resulted in a neutrophil inﬂux into the utero-
placental tissues, immunohistochemistry was performed withajp.amjpathol.org - The American Journal of Pathology
Table 1 Effect of Ultrasound-Guided Intrauterine LPS Adminis-
tration on mRNA Expression of Inﬂammatory Genes in the Utero-
placental Tissues
Tissue Gene Fold change versus PBS
Uterus Cxcl1 414.14****
Cxcl2 212.65****
Ccl2 110.95****
Il1b 47.19****
Il6 319.17****
Ptgs2 13.96****
Tnfa 10.96****
Fetal membranes Cxcl1 12.10***
Cxcl2 22.90****
Ccl2 5.20**
Il1b 11.65****
Il6 2.39
Ptgs2 2.75**
Tnfa 4.31***
Placenta Cxcl1 39.13****
Cxcl2 73.10****
Ccl2 7.34****
Il1b 11.85****
Il6 19.17****
Ptgs2 2.57****
Tnfa 7.79****
Uterine, placental, and fetal membranes were collected 6 hours after
treatment from mice administered intrauterine PBS (nZ 6) or 20 mg of LPS
(nZ 6), under ultrasound guidance. The mRNA expression of Cxcl1, Cxcl2,
Ccl2, Il1b, Il6, Ptgs2, and Tnfa was quantiﬁed by quantitative real-time PCR.
Data are expressed as mean fold change.
**P < 0.01, ***P < 0.001, and ****P < 0.0001.
New Mouse Model of Preterm Birthan antieLy-6G antibody on uterine tissue and fetal mem-
branes collected 6 hours after LPS or PBS treatment and also
from untreated mice at D17 of gestation as a comparator.
Neutrophils were not present in the uterine tissue of untreated
mice on D17 of gestation (Figure 3A) or PBS-treated miceFigure 3 Effect of ultrasound-guided intrauterine LPS administration on neutro
neutrophils localized by immunohistochemistry for Ly-6G in uterine tissue and fet
trauterine LPS or PBS under ultrasound guidance and from untreated mice on day 17
collected from untreated mice (A) or PBS control mice (B). C: Decidual neutrophi
control section. No neutrophils were present in fetal membranes collected from untr
mice (G). H: Fetal membrane negative control. nZ 6 (LPS or PBS), nZ 3 (untrea
The American Journal of Pathology - ajp.amjpathol.org(Figure 3B). In uterine tissue collected frommice treated with
LPS there was evidence of decidual neutrophil inﬁltration
(Figure 3C). In the fetal membranes, no neutrophils were
observed in the fetal membranes collected from untreated
mice on D17 of gestation (Figure 3E) or from PBS-treated
mice (Figure 3F). Although most ﬁelds were negative for
Ly-6Gþ neutrophils in the fetal membranes of LPS-treated
mice (Figure 3G), occasional Ly-6Gþ neutrophils were
observed. Negative control sections are shown in Figure 3, D
(uterus) and H (fetal membranes).
Discussion
Animal models of PTB are essential to improve our under-
standing of the mechanisms underlying the onset of preterm
labor and for investigating the potential of treatments to delay
preterm delivery and improve neonatal outcome. Here, we
report the development of a novel, minimally invasive model
of localized intrauterine inﬂammation-induced PTB, using
ultrasound-guided intrauterine LPS administration.
Intrauterine LPS administration is commonly used as a
model of inﬂammation-induced PTB.5,11e13,19e22 However,
as our data show, the traditional laparotomy method is
associated with a relatively variable response, particularly in
the control group. The surgical nature of this method can
result in PTB in mice treated only with PBS (ie, in the
control group) and subsequently affects the proportion of
live born pups in this group; therefore, results are more
difﬁcult to interpret and a larger sample size is required. In
comparison, we found that the use of ultrasound to guide the
intrauterine injection still resulted in signiﬁcantly earlier
delivery in the LPS-treated mice, but importantly it did not
result in any PTB in the PBS control group, and these mice
had a consistently high proportion of live born pups.
Minimizing the invasive nature of the surgery not onlyphil inﬁltration of the uterus and fetal membranes. Representative images of
al membranes collected 6 hours after treatment from mice administered in-
of gestation as a comparison. No neutrophils were observed in uterine tissue
l inﬁltration was observed in LPS-treated mice (arrows). D: Uterus negative
eated (E) or PBS control (F) mice or in the majority of ﬁelds from LPS-treated
ted mice). Original magniﬁcation, 20. LPS, lipopolysaccharide.
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Rinaldi et alappears to reduce the variability but is also an important
reﬁnement of the model and is consistent with the principles
of replacement, reduction, and reﬁnement, which should
underpin all studies that involve animals.23
In addition, our data show that ultrasound-guided intra-
uterine LPS administration results in a local inﬂammatory
response within the uteroplacental tissues, with up-regulation
of a number of inﬂammatory genes commonly associated
with parturition and an inﬂux of neutrophils into the decidua.
These ﬁndings are in agreement with previously published
studies that used the laparotomy model of intrauterine
inﬂammation,11e13,19,21 therefore conﬁrming that ultrasound-
guided intrauterine LPS administration results in a similar
response to the invasive laparotomy model. Importantly, in
contrast to our previously published studies that used the
laparotomy model,11 we did not observe neutrophil inﬁltra-
tion in the uterine tissue of PBS-treatedmice, highlighting that
the use of ultrasound-guided intrauterine injection minimizes
the inﬂammatory response in the control animals.
Conclusion
We have shown that ultrasound-guided intrauterine LPS
administration reliably induces PTB in the mouse and mimics
the local inﬂammatory and immune response observed in other
more-invasive models of inﬂammation-induced PTB. We
believe that the development of this new minimally invasive
method of inﬂammation-induced PTBwill be useful to improve
our understanding of themechanisms underlying inﬂammation-
induced PTB and for future analysis of novel therapeutic
interventions to prevent PTB and improve neonatal outcome.
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